Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Canadian Respiratory Journal
Volume 19 (2012), Issue 2, Pages 109-116
http://dx.doi.org/10.1155/2012/920918
Special Article

Alpha-1 Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Clinical Practice Guideline

DD Marciniuk,1 P Hernandez,2 M Balter,3 J Bourbeau,4 KR Chapman,4 GT Ford,5 JL Lauzon,5 F Maltais,6 DE O’Donnell,7 D Goodridge,1 C Strange,8 AJ Cave,9 K Curren,10 S Muthuri,10 and Canadian Thoracic Society COPD Clinical Assembly Alpha-1 Antitrypsin Deficiency Expert Working Group

1University of Saskatchewan, Saskatoon, Saskatchewan, Canada
2Dalhousie University, Halifax, Nova Scotia, Canada
3University of Toronto, Toronto, Ontario, Canada
4McGill University, Montreal, Quebec, Canada
5University of Calgary, Calgary, Alberta, Canada
6Laval University, Laval, Quebec, Canada
7Queen’s University, Kingston, Ontario, Canada
8Medical University of South Carolina, Charleston, South Carolina, USA
9University of Alberta, Edmonton, Alberta, Canada
10Canadian Thoracic Society, Ottawa, Ontario, Canada

Copyright © 2012 Canadian Thoracic Society. This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes.

How to Cite this Article

DD Marciniuk, P Hernandez, M Balter, et al., “Alpha-1 Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Clinical Practice Guideline,” Canadian Respiratory Journal, vol. 19, no. 2, pp. 109-116, 2012. doi:10.1155/2012/920918